1-10 of 10
Jeffrey Scott
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quality initiative in first-line chronic lymphocytic leukemia /small lymphocytic lymphoma assessing the use of 2nd generation BTKi therapy and impact on cardiac medical conditions patients experience on treatment

Free
Jing-Zhou Hou, Tejvir Singh, Wesley Falconer, Patrick Travis, Olalekan Ajayi, Jason Stinnett, Kyle Kitchen, Anna Rui, Mike Gart, Lisa Kunst, Lindsay Aton, Poras Dave, Doug Kanovsky, Brandon Wang, Prateesh Varughese, Robert Geller, Jeffrey Scott, Rushir Choksi
Journal: Blood
Blood (2025) 146 (Supplement 1): 7934.
https://doi.org/10.1182/blood-2025-7934
Published: 2025
Journal Articles

Evaluation of real-world outcomes among CLL patients based on sequencing of BTKi and BCL2i therapies

Free
Taral Patel, Rushir Choksi, Tejvir Singh, Aliakbar Dadla, Thomas Weart, Brian Mulherin, Fred Kudrik, Gelareh Rahimi, Gino Cioffi, Don Parris, Anna Rui, Mike Gart, Lisa Kunst, Lindsay Aton, Poras Dave, Doug Kanovsky, Janet Donegan, Lisa Morere, Jeffrey Scott, Jing-Zhou Hou
Journal: Blood
Blood (2025) 146 (Supplement 1): 6286.
https://doi.org/10.1182/blood-2025-6286
Published: 2025
Journal Articles

Initial performance of pirtobrutinib: Real-world outcomes among CLL patients after prior covalent-BTKi and BCL2i use

Free
Rushir Choksi, Aliakbar Dadla, Thomas Weart, Brian Mulherin, Taral Patel, Fred Kudrik, Tejvir Singh, Steven Champaloux, John Li, Anna Rui, Gino Cioffi, Don Parris, Mike Gart, Janet Donegan, Lisa Morere, Lisa Kunst, Lindsay Aton, Jeffrey Scott, Jing-Zhou Hou
Journal: Blood
Blood (2025) 146 (Supplement 1): 6285.
https://doi.org/10.1182/blood-2025-6285
Published: 2025
Journal Articles

Real-world incidence of treatment-emergent cardiovascular events among chronic lymphocytic leukemia/small lymphocytic lymphoma patients receiving acalabrutinib or zanubrutinib monotherapy

Free
Jing-Zhou Hou, Rushir Choksi, Anna Rui, Vikram Shetty, Anna Teschemaker, Kathy Wojtas, Steven Champaloux, Dipen Patel, Doug Kanovsky, Jeffrey Scott, Aliakbar Dadla, Daniel Allendorf
Journal: Blood
Blood (2025) 146 (Supplement 1): 4506.
https://doi.org/10.1182/blood-2025-4506
Published: 2025
Journal Articles

Real-world comparison of treatment outcomes between BCL2i and 2nd generation BTKi therapy in first-line CLL patients

Free
Rushir Choksi, Aliakbar Dadla, Thomas Weart, Brian Mulherin, Taral Patel, Fred Kudrik, Tejvir Singh, Anna Rui, Gino Cioffi, Don Parris, Mike Gart, Janet Donegan, Lisa Morere, Lisa Kunst, Lindsay Aton, Poras Dave, Doug Kanovsky, Jeffrey Scott, Jing-Zhou Hou
Journal: Blood
Blood (2025) 146 (Supplement 1): 4505.
https://doi.org/10.1182/blood-2025-4505
Published: 2025
Journal Articles

Quality initiative in first-line multiple myeloma assessing the use of anti-CD38 agents and quadruplet therapy

Free
Joseph Franz, Dhaval Mehta, Kathleen Dorritie, Rushir Choksi, Taya Salman, Mike Gart, Lisa Kunst, Harshal Dave, Kristen Henn, Prashanth Jain, Brandon Wang, Prateesh Varughese, Lisa Morere, Jeffrey Scott, Paul Richardson
Journal: Blood
Blood (2025) 146 (Supplement 1): 8120.
https://doi.org/10.1182/blood-2025-8120
Published: 2025
Journal Articles

Factors impacting treatment choice with a CD38 antibody, immunomodulator, proteasome inhibitor, and dexamethasone in first line multiple myeloma patients: A real-world US study

Free
Joseph Franz, Joseph Mikhael, Dhaval Mehta, Rushir Choksi, Taya Salman, Mike Gart, John Li, Harshal Dave, Lisa Kunst, Kristen Henn, Prashanth Jain, Brandon Wang, Prateesh Varughese, Lisa Morere, Jeffrey Scott, Paul Richardson
Journal: Blood
Blood (2025) 146 (Supplement 1): 3988.
https://doi.org/10.1182/blood-2025-3988
Published: 2025
Journal Articles

Siremadlin (HDM201) Is Well Tolerated and Demonstrates Clinical Activity in Patients with Acute Myeloid Leukemia Who Have Relapsed after Allogeneic Stem Cell Transplantation: A Subset Analysis of Safety and Preliminary Efficacy

Free
Eytan M. Stein, Jörg Chromik, Cecilia Carpio, Rogier Mous, Jean-Jacques Kiladjian, Gheath Alatrash, Antonio Curti, Charles Craddock, Christoph Schmid, Robert Zeiser, Lamis K. Eldjerou, Hans-Jochen Jochen Weber, Claire Fabre, Jeffrey Scott, Daniel J. DeAngelo
Journal: Blood
Blood (2021) 138 (Supplement 1): 3417.
https://doi.org/10.1182/blood-2021-149751
Published: 2021
Journal Articles

The STIMULUS Program: Clinical Trials Evaluating Sabatolimab (MBG453) Combination Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) or Acute Myeloid Leukemia (AML)

Free
Amer M. Zeidan, MBBS, MHS, Jordi Esteve, Aristoteles Giagounidis, Hee-Je Kim, MD, PhD, Yasushi Miyazaki, MD PhD, Uwe Platzbecker, Andre C. Schuh, Mikkael A. Sekeres, Jörg Westermann, Zhijian Xiao, Kamel Malek, Jeffrey Scott, Julie Niolat, Severine Peyrard, Fei Ma, Flavia Kiertsman, Mario Stegert, Sabine Hertle, Pierre Fenaux, MD PhD, Valeria Santini
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-134718
Published: 2020
Journal Articles

Budget Impact Model for Hypomethylating Agent Use for the Treatment of Myelodysplastic Syndromes (MDS)

Free
Bruce Feinberg, DO, Jeffrey Scott, MD, Susan Weidner, Barry Fortner, PhD
Journal: Blood
Blood (2008) 112 (11): 2397.
https://doi.org/10.1182/blood.V112.11.2397.2397
Published: 2008